Introduction to Partner 3 Trial
Let's dive into the details surrounding Partner 3 Trial. Dr Michael Mack (Baylor Scott & White Heart Hospital, Plano, US) joins us to share the clinical and echocardiographic outcomes ...
Partner 3 Trial Comprehensive Overview
Dr Michael J Mack (Baylor Scott & White Heart Hospital, Plano, TX, US) discusses the two-year clinical and echocardiographic ... Martin Leon, MD and Michael Mack, MD provide an overview of the results of Dr. Vinod H. Thourani gives the
In structural cardiology, TAVI has been further validated for low-risk patients. The most recent
Summary & Highlights for Partner 3 Trial
- Dr. Lars Svensson, Chairman of the Heart and Vascular Institute and Dr. Samir Kapadia, Section Head, Interventional Cardiology ...
- In this short virtual interview, we are joined by Dr Martin B Leon (Columbia University Medical Center, US) to discuss the 5-year ...
- Mirvat Alasnag interviews Michael J. Mack about the seven-year clinical and echocardiographic outcomes of the
- No audio (I have been too busy lately but I promise I'll do this at some point!) You can download the slides here: ...
- Michael Mack, M.D., an author on the
That wraps up our extensive overview of Partner 3 Trial.
